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Background:Oxidative stress is a key event in the determination of host cell fate.
Results: The hepatitis C virus NS5A protein binds to the MLK3 kinase, blocking both oxidative stress induced apoptosis and
activation of the potassium channel Kv2.1.
Conclusion: NS5A blocks host cell apoptosis and potassium efflux.
Significance: Interference with the host stress response could facilitate viral persistence.
Hepatitis C virus (HCV) infection results in the activation of
numerous stress responses including oxidative stress, with the
potential to induce an apoptotic state. Previouslywehave shown
that HCV attenuates the stress-induced, p38MAPK-mediated
up-regulation of the K channel Kv2.1, to maintain the survival
of infected cells in the face of cellular stress. We demonstrated
that this effect wasmediated byHCV non-structural 5A (NS5A)
protein, which impaired p38MAPK activity through a polypro-
line motif-dependent interaction, resulting in reduction of
phosphorylation activation of Kv2.1. In this study, we investi-
gated the host cell proteins targeted by NS5A to mediate Kv2.1
inhibition. We screened a phage-display library expressing the
entire complement of humanSH3domains for novelNS5A-host
cell interactions. This analysis identifiedmixed lineage kinase 3
(MLK3) as a putative NS5A interacting partner. MLK3 is a ser-
ine/threonine protein kinase that is a member of the MAPK
kinase kinase (MAP3K) family and activates p38MAPK. An
NS5A-MLK3 interaction was confirmed by co-immunoprecipi-
tation and Western blot analysis. We further demonstrate a
novel role ofMLK3 in themodulation of Kv2.1 activity, whereby
MLK3 overexpression leads to the up-regulation of channel
activity. Accordingly, coexpression of NS5A suppressed this
stimulation. Additionally we demonstrate that overexpres-
sion of MLK3 induced apoptosis, which was also counter-
acted by NS5A. We conclude that NS5A targets MLK3 with
multiple downstream consequences for both apoptosis and
K homeostasis.
Hepatitis C virus (HCV)4 is a highly pathogenic human virus
associated with liver fibrosis, steatosis, and cancer (1). HCV is
an enveloped virus belonging to the Hepacivirus genus of the
family Flaviviridae. The HCV genome comprises a 9.6 kb RNA
with sense strand polarity containing a single open reading
frame (ORF) of 3000 amino acids, flanked by highly con-
served un-translated regions. The polyprotein is co- and post-
translationally processed by host and viral proteases resulting
in 10 individual viral proteins, the structural proteins core, E1,
E2, and p7 and the non-structural proteins NS2, NS3, NS4A,
NS4B, NS5A, and NS5B (2).
HCV establishes a persistent infection meaning it must
maintain the viability of virus-infected cells. While the survival
of infected cells is critical for viral pathogenesis, the molecular
mechanisms by which HCV achieves this still remain largely
uncharacterized. In this regard, NS5A is a protein of particular
interest as, in addition to its direct role in both viral replication
(3) and virion production (4–6), it is known to bind numerous
host cell proteins which are involved in cellular signaling path-
ways (7). NS5A mediates some of these effects via polyproline
(PXXPXR) motifs, one of which in particular (termed P2) is
absolutely conserved in all HCV isolates fromall 7 genotypes (8,
9). PXXPXR motifs form extended helical structures and are
present in a plethora of viral and cellular proteins involved in
cell signal transduction. They bind to Src homology 3 (SH3)
domains found in a range of signal-transducing molecules.
Ion channels play a major role in the maintenance of ionic
homeostasis. Acute enhancement of voltage-gated K channel
activity can result in the initiation of apoptosis (10). P38 mito-
gen-activated protein kinases (p38MAPK) are mitogen-acti-
vated protein kinases activated in response to stress stimuli,
including cytokines and heat shock, that are involved in cell
differentiation and apoptosis (11, 12). It was recently demon-
strated that in response to oxidative stress, activated p38MAPK
phosphorylates the Kv2.1 protein, whichmediates an K efflux
with a concomitant induction of apoptosis (10, 13). We previ-
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ously identified that HCV NS5A inhibits the function of Kv2.1
by inhibiting p38MAPK signaling, an effect mediated through
the P2 motif. Accordingly, when the P2 motif was mutated
(termed PA2) (Fig. 1A) in the context of the HCV isolate JFH1,
the virus did not block activation of p38MAPK or Kv2.1, and
infected cells were sensitive to oxidant-induced apoptosis (14).
In the present study, we aimed to dissect further the mecha-
nism of NS5Amediated p38MAPK and subsequent Kv2.1 inhi-
bition. We screened a phage-display library expressing the
entire complement of human SH3 domains, identifying mixed
lineage kinase 3 (MLK3), a serine/threonine protein kinase that
functions as a mitogen-activated protein kinase kinase kinase
(MAP3K) to activate p38MAPK, as aNS5A interacting partner.
MLK3 is a kinase that activates c-Jun NH2-terminal kinase
(JNK) and p38MAPK (15). A schematic of the structure of
MLK3 is shown in Fig. 1A. It is known as a regulator of neuronal
apoptosis (16), cytokine-induced apoptosis of hepatoma cells
(17), anddrug-induced liver injury (18). In this study,we further
demonstrate that MLK3 activates Kv2.1 and induces cellular
apoptosis, processes suppressed by HCV NS5A in a P2-depen-
dent manner. These data indicate that NS5A counteracts oxi-
dative-stress induced apoptosis and the activation of Kv2.1-
mediated K efflux through the perturbation of MLK3/
p38MAPK signaling.
EXPERIMENTAL PROCEDURES
Cell Culture—Human hepatoma cell lines, Huh7 and
Huh7.5, were maintained in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% fetal bovine serum,
100 units/ml penicillin, 100 g/ml streptomycin, 1 mM non-
essential amino acids, and 2 mM GlutaMax (Invitrogen, Carls-
bad, CA). HEK293 Flp-in Tet-on cells were a kind gift from
Adrian Whitehouse (University of Leeds, UK) and have been
established per the manufacturer’s instructions (Invitrogen,
Carlsbad, CA).
Reagents—2,2-Dithiodipyridine (DTDP) (Sigma) was dis-
solved in dimethyl sulfoxide (Hybri-Max, Sigma) and used at 25
M in the culture medium. Tetracycline (Sigma) was dissolved
in ethanol and added to the culture medium to induce protein
expression from the tetracycline-regulated promoter at a con-
centration of 10 ng/ml, unless otherwise noted.
Plasmids—pJFH1 was provided by Takaji Wakita (National
Institute of Infectious Disease, Japan) and described previously
(19). pRG4-Kv2.1 and its corresponding S800A and S800E
mutants were provided by Elias Aizenmann (University of
Pittsburgh) and described in (13). The cDNAs were used to
construct pcDNA5-FRT/TO-Kv2.1 by conventional recombi-
nant DNA techniques. pcDNA-FLAG-MLK3 and the corre-
sponding kinase dead mutant (K144E) were provided by Frie-
demannKiefer (Max-Planck Institute, Germany) and described
in Ref. 20. For the generation of bicistronic expression vectors
expressing different combinations of NS5A and GFP or MLK3
and GFP (Fig. 1B), protein coding sequences were amplified by
PCR using pJFH1 or pcDNA3-FLAG-MLK3 as template DNA,
respectively (all primer sequences available on request). Ampli-
fied DNA fragments were digested with XbaI and AscI then
cloned intoXbaI andMluI digested froma pCG-Nef-IRES-GFP
vector (21). To construct pCG-FLAG-MLK3-IRES-NS5AGFP,
an in-frame fusion of NS5A and GFP was created by PCR and
recloned into the corresponding sites of pCG-FLAG-MLK3-
IRES-GFP. The One STrEP-tagged subgenomic replicon clone
pSGR-JFH1–5A1ST was described previously (22). The PA2
mutation to disrupt the P2 SH3 binding motif was described
previously (23) and was introduced into pSGR-JFH1–5A1ST
by conventional molecular cloning techniques. One-STrEP-
tagged replicon cell lines and STrEP-tactin affinity column
purification were made and performed as described previously
(22).
Lentiviral Vector System for shRNA Delivery—pCS-RfA-EG
and a set of packaging plasmid vectors, including pCMV-VSV-
G-RSV-Rev and pCAG-HIVgp, were obtained from Hiroyuki
Miyoshi (Riken BioResorce Center, Japan). To construct
shRNA expressing lentiviral vectors, a pair of 65-mer oligonu-
cleotides was inserted into BglII and XbaI sites of pENTR4-H1.
Oligonucleotide sequences for constructing shGFP and
shMLK3 are available upon request. The shRNA encoding
insert was confirmed by DNA sequencing. The shRNA
expression unit in pENTR4 was inserted into pCS-RfA-EG
by Gateway LR clonase II (Invitrogen) directed DNA
recombination per the manufacturer’s recommendation. To
obtain lentiviral particles, packaging transfections were per-
formed using Fugene 6 (Promega), as per the manufacturer’s
recommendations.
mRNAQuantitation by qRT-PCR—Total RNA samples were
extracted by using Trizol reagent following the manufacturer’s
instruction. pcDNA3-FLAG-MLK3 vector was linealized by
SalI restriction enzyme and treated with mung bean nuclease.
Linearized vector was phenol/chloroform extracted for purifi-
cation and used as template DNA for in vitro T7 transcription.
Transcribed RNA was purified by phenol/chloroform extrac-
tion and examined for their homogeneity prior to use as copy
number control samples for quantitative reverse-transcriptase
PCR. 100 ng total RNA was combined with 250 ng of random
hexamer and subjected to first strand synthesis using super-
script II reverse transcriptase. qRT-PCR was performed as
described previously in Ref. 22 (primer sequences available
upon request).
Establishment of HEK293 lines for Conditional Kv2.1
Expression—To establish a stable cell line expressing Kv2.1
under a tetracycline regulated promoter, knock-in transfec-
tions were performed as per the manufacturers’ instruction.
Briefly, HEK293 Flp-in Tet-on cells were seeded into 6-
well plates and transfected with pcDNA5 FRT/TO-Kv2.1
together with pOG44 using Trans-it LT1 reagent (Mirus
Bio). Forty-eight hours post-transfection, cells were selected
with 100 g/ml hygromycin B for 3 weeks. Colonies were
then isolated using cloning cylinders and expanded for fur-
ther characterization.
Indirect Immunofluorescence Microscopy—Cells grown on
glass coverslips were washed twice with PBS and fixed with 4%
paraformaldehyde in PBS supplemented with 2 mMMgCl2 and
1.25 mM EGTA, for 1 h at room temperature. Fixed cells were
labeled with primary antibodies overnight in antibody-binding
buffer (PBS with 0.2% saponin, 0.2% nonfat dry milk, and 1%
bovine serum albumin). After washing cells 4 times in PBS, cells
were further incubated with fluorescent secondary antibodies
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for 4 h, rinsed, andmountedwith Prolong gold antifade reagent
(Invitrogen).
Western Blotting and Immunoprecipitation Analysis—For
surface protein labeling on plasmamembrane, EZ-Link Sulfo-
NHS-SS-biotin (Pierce) was used as following manufacturer’s
instruction. Biotin-labeled plasma membrane proteins were
collected with streptavidin magnetic beads (New England Bio-
labs) and subjected to Western blotting analysis. Equal num-
bers of cells (1  106) were subjected for this analysis.
The primary and secondary antibodies used in this study are
listed as follows. Sheep anti-NS5A was described previously
(24). Anti-FLAG antibody (mouse monoclonal clone M2) was
purchased from Agilent technologies. Anti-MLK3 antibody
(mouse monoclonal clone D-11) was from Santa Cruz Biotech-
nology Inc. Anti-GAPDH antibody (mouse monoclonal clone
6C5) was obtained from Abcam. Anti-phospho-p38 MAPK
(Thr-180/Tyr-182) clone 12F8was fromCell Signaling technol-
ogy. Anti-Kv2.1 antibody (mouse monoclonal clone K89/34)
was obtained from NeuroMab. Rabbit anti-phospho Kv2.1
(S800) antibody was provided by Elias Aizenman (University of
Pittsburgh). For secondary antibody, peroxidase-conjugated
anti-mouse IgG, anti-sheep IgG, and anti-rabbit IgG were
obtained from Sigma. Detected protein signal intensities were
analyzed by NIH ImageJ software. For immunoprecipitations,
Huh7 cells were lysed in 0.25% deoxycholic acid, 0.1% Triton
X-100, 150 mM NaCl, 100 mM Tris/HCl pH 8.0. After brief
sonification and centrifugation, 0.5 ml of each cleared lysate
was incubated with 2 g of anti-FLAG monoclonal antibodies
(clone M2- Agilent) for 1 h at 4 °C. Immuno-complexes were
captured with protein G Sepharose beads by incubation at 4 °C
for 1 h. Bound immuno-complexes were washed four times
with 1ml of lysis buffer and once with Tris-buffered saline. The
band intensities were measured using NIH ImageJ 1.63
software.
Electrophysiological Recordings of K Currents—Cells grown
on coverslips were placed on a continuously perfused recording
chamber, which was mounted on an inverted fluorescence
microscope. Patch pipette resistance was between 4–6 M,
andG seals were obtained before proceeding to rupturing the
plasmamembrane for whole cell recordings. To record K cur-
rents, a series of depolarizing steps (500 ms duration, applied
every 5s) from 100 to 60 mV in 10 mV increments, were
applied to cells which were otherwise clamped at 70 mV.
Voltage-clamp and data acquisition were performed with the
use of Axopatch 200A amplifier/Digidata 1200 interface con-
trolled by Clampex 9.0 software (Molecular Devices). On-line
leak subtraction was applied using a P/4 protocol, and offline
data analysis was performed by Clampfit 9.0 (Molecular
Devices). Results were presented asmeans S.E. (n 5, unless
otherwise noted), and statistical analysis was performed using
unpaired Student’s t-tests, where p values were indicated in
each figure legends. p 	 0.05 was considered statistical signifi-
cant. Recordings were performed using the following solutions:
Pipette solution; 10 mM HEPES/KOH (pH 7.2), 140 mM KCl, 5
mM EGTA, 2 mM MgCl2, 1 mM CaCl2, and 10 mM D-glucose.
Perfusate buffer; 10 mMHEPES/KOH (pH7.2), 140 mMNaCl, 5
mM KCl, 2 mM MgCl2, 2 mM CaCl2, and 10 mM D-glucose.
RESULTS
NS5A Binds to Mixed Lineage Kinase 3 via a Conserved Poly-
prolineMotif—NS5A interactswith a range of host cell proteins
to modulate their function and promote virus replication and
pathogenesis. In this regard, NS5A contains a proline-rich
motif (with the sequence PXXPXR), designated as P2, which
binds to Src homology 3 (SH3) domains (23). Thismotif is abso-
lutely conserved in all HCV isolates in the LosAlamos database,
implying that it must play some role in the virus lifecycle. Par-
adoxically, mutation of this motif by alanine substitution of the
FIGURE 1. A, molecular organization of MLK3 and HCV NS5A. Schematic illustration of the domain structure of the two proteins. Amino acid residue numbers
indicated. The sequence of the P2 motif and the mutations introduced to generate the PA2 mutant are illustrated. The black box on NS5A is the N-terminal
membrane-associating amphipathic helix. B, structure of bicistronic vectors used for transfection in this study. The construction of these vectors is detailed in
the “Experimental Procedures.”
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key prolines (termed PA2) has no effect on virus replication
(23).
In an attempt to ascribe a function to the P2 motif, we previ-
ously reported that HCV attenuates outward K currents
mediated by the Kv2.1 channel in a P2 dependent manner (14),
whereby channel activity was found to be impaired by inhibi-
tion of p38MAPK phosphorylation of serine 800 (S800) in the
C-terminal cytoplasmic domain of Kv2.1. To investigate the
molecular mechanism of this effect, we screened a phage dis-
play library expressing the entire complement of human SH3
domains (25) to identify putative NS5A interacting partners.
This screen led to the identification of mixed lineage kinase 3
(MLK3) (Fig. 1A) as a P2-dependent NS5A interacting partner.
Interestingly, MLK3 is an upstream activator of p38MAPK,
modulating its phosphorylation in response to cytokine and
oxidative stress (17, 26, 27). Thus MLK3 was a likely candidate
to mediate the NS5A effect on p38MAPK and Kv2.1 activities.
We sought to confirm this interaction by co-immunopre-
cipitation. Endogenous MLK3 was immunoprecipitated from
lysates of Huh7 cells stably harboring a JFH1-derived sub-
genomic replicon,Western blot analysis of the immunoprecipi-
tates demonstrated the presence of bothMLK3 and NS5A (Fig.
2A), while immunoprecipitationwith a control IgGdid not cap-
ture either MLK3 or NS5A. We undertook the reciprocal
FIGURE 2. NS5A binds to MLK3 in a polyproline motif (P2)-dependent manner. A, lysates from Huh7 cells harboring a JFH-1 derived subgenomic replicon
(SGR-JFH1) were immunoprecipitated with an anti-MLK3 monoclonal antibody and analyzed by Western blot for the presence of MLK3 and NS5A. The top panel
shows the lysates and the bottom panel the immunoprecipitates, IgG LC: light chain of the immunoprecipitating antibody. B, lysates from Huh7 cells harboring
an SGR with a One-STrEP-tagged NS5A were purified by affinity column capture with Strep-Tactin beads, prior to Western blotting for the presence of NS5A and
MLK3. C, SGR-JFH1 cells were analyzed by indirect immunofluorescence with antibodies to NS5A (red) and MLK3 (green). The merged image shows extensive
colocalization of the two proteins. Scale bar, 20 m. D, ectopic expression of NS5A and MLK3, co-immunoprecipitation/Western blotting to demonstrate
protein-protein interaction between NS5A and MLK3. Huh7 cells were co-transfected with a combination of plasmid vectors expressing NS5A (wild type or PA2
mutant) and FLAG-tagged MLK3 (wild type or K144E kinase-dead mutant, MLK3 KD) as indicated. Lysates were immunoprecipitated with an anti-FLAG
antibody and Western blotted for the presence of NS5A or MLK3. IgG LC: light chain of the immunoprecipitating antibody. E, Huh7 cells were transfected with
plasmid vectors expressing NS5A (top row), FLAG-tagged MLK3 (middle row), or both (bottom row). Indirect immunofluorescence microscopy reveals colocal-
ization of NS5A and MLK3 in the cotransfected cells.
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experiment by affinity capture purification from lysates of
Huh7 cells harboring a subgenomic replicon containing a one-
STrEP-tag within NS5A. Lysates from wild type (untagged), or
tagged replicon cells (NS5A wild type or PA2 mutation) were
subjected to STrEP-tactin Sepharose column purification.
Comparable amounts of NS5A were expressed in all three cell
lines as seen in Fig. 2B (left), however as expected after affinity
capture purification, NS5A was only precipitated and eluted
when tagged. MLK3 was co-purified with either wild type or
PA2 NS5A, but densitometry revealed that a lesser amount of
MLK3 was associated with PA2 NS5A, (Fig. 2B, right). In sup-
port of the coimmunoprecipitation data, indirect immunofluo-
rescence analysis revealed that NS5A and MLK3 were colocal-
ized in perinuclear regions of subgenomic replicon harboring
cells (Fig. 2C).
To further investigate the requirements for the interaction
between NS5A and MLK3, Huh7 cells were transfected with
plasmids expressing wild type or PA2 NS5A (genotype 2a
JFH-1) and FLAG-tagged MLK3. Ectopic expression of MLK3
leads to autocatalytic self-activation. For this reason, wild type
MLK3 appears as multiple bands of different molecular weight
(Fig. 2D, lanes 4–6, 2nd panel). In contrast, a kinase-inactive
mutant of MLK3, where lysine 144 was substituted with glu-
tamic acid (K144E) to eliminate ATP binding, always appeared
as a single band (Fig. 2D, lanes 7–9, 2nd panel). Intriguingly,
NS5A co-precipitated only with wild typeMLK3 (lanes 5 and 6,
4th panel), but did not interact with the kinase inactive form of
MLK3 (lanes 8 and 9). Further to this, when coexpressed with
wild type MLK3, but not the K144E mutant, NS5A also exhib-
ited an additional highmolecular weight species (lanes 5 and 6),
consistent with the presence of the hyperphosphorylated (also
referred to as p58)NS5A species in subgenomic replicon lysates
(see Fig. 2A). This suggests that the interaction betweenMLK3
andNS5Amay alter the phosphorylation status of NS5A, either
by directly phosphorylatingNS5A, ormodulating the activity of
another (as yet unidentified) NS5A kinase. The interaction of
NS5A and MLK3 was significantly impaired by the PA2 muta-
tion (compare lanes 5 and 6). In further support of this interac-
tion, we demonstrated by indirect immunofluorescence
microscopy that NS5A and FLAG-MLK3 colocalized in tran-
siently transfected cells (lower panel, Fig. 2E). Our data are con-
sistent with a direct interaction between NS5A and MLK3,
mediated in part by the P2 motif of NS5A.
NS5A InhibitsMLK3 Induced Apoptosis in a P2Motif-depen-
dentManner—Wepreviously demonstrated that the inhibition
of Kv2.1 activity by NS5A was accompanied by a concomitant
FIGURE 3. Exogenous MLK3 expression induces apoptosis. A, Huh7 cells were seeded on coverslips and transfected with the indicated expression vectors.
24 h after transfection, cells were fixed and stained with DAPI. Fluorescence microscopy was performed to visualize transfected cells (GFP fluorescence) and the
nucleus (DAPI). B, multiple fields were counted (n  4). GFP-positive cells, more than 60 cells for each sample point, were counted as transfected cells and the
percentage of GFP-positive cells showing fragmented nuclei are presented. C, Huh7 cells were transfected with the indicated plasmid vectors. Lysates were
subjected to Western blotting to detect caspase-cleaved PARP (as a marker of apoptosis), as well as NS5A-GFP and FLAG-MLK3.
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protection of infected cells from oxidative stress-induced apo-
ptosis (14). However, it was not clear whether this protection
from apoptosis was due to the block in K efflux, or some other
consequence of the inhibition of p38MAPK signaling. To
address this question we next sought to determine the down-
stream effects of the NS5A-MLK3 interaction. In particular we
wished to assess whetherMLK3 couldmediate the induction of
apoptosis and, if so, whether NS5A could abrogate this effect. It
had been previously shown that when ectopically overex-
pressed wild type MLK3 can function as a dominant active
kinase via homo-dimerization and subsequent auto-phospho-
rylation activation, whereas the kinase-inactive K144E mutant
functioned as a dominant negative (28). Huh7 cells were there-
fore transfected with bicistronic constructs expressing MLK3
(eitherwild type orK144E) and eitherGFP or aNS5A (wild type
or PA2) GFP fusion (Fig. 1B). The induction of apoptosis was
assessed by the presence of fragmented nuclei at 24 h after
transfection. Fig. 3A shows that, whereas either GFP or NS5A-
GFP expression did not induce apoptosis, as anticipated ectopic
MLK3 expression resulted in significant induction of apoptosis.
Interestingly, expression of K144E MLK3 did not induce apo-
ptosis suggesting that MLK3-mediated cell death is mediated
by the kinase activity of MLK3. When MLK3 was expressed
together with wild type NS5A-GFP,MLK3-mediated cell death
was inhibited. Importantly, this inhibition was not observed
upon co-expression of PA2 NS5A (Fig. 3A-VI). These results
were quantified and expressed as an apoptotic cells in the GFP
positive population (Fig. 3B). To confirm the induction of apo-
ptosis by MLK3, we utilized an alternative assay for the
caspase-3 mediated cleavage of poly[ADP-ribose]polymerase
(PARP), a well characterized apoptosis effector molecule. Wild
type MLK3 induced strong activation of PARP (Fig. 3C, lane 2)
whereas this effect was abrogated by the K144E mutation of
MLK3 (Fig. 3C, lane 3). Cotransfection of wild type NS5A, but
not the PA2 mutant, blocked the appearance of cleaved PARP
(lanes 4 and 5). Taken together, these observations suggest that
NS5A interacts with MLK3 and inhibits its kinase activity
and/or accessibility to substrate proteins, thus blockingMLK3-
induced apoptosis.
NS5A Suppresses Outward K Current by Inhibiting the
Kv2.1 Channel—As we previously reported, the inhibition of
both apoptosis and the activity of the Kv2.1 channel were
dependent on the P2 motif within NS5A (14). Taken together
with the results shown in Figs. 2 and 3, we therefore considered
that MLK3 might also contribute to Kv2.1 regulation. To test
this, and further elucidate the mechanism by which NS5A
inhibited Kv2.1 activity, we established a novel model cell line
for electrophysiological measurement of Kv2.1 activity and its
regulation. Stable HEK293 cell lines expressing either wildtype
Kv2.1, a non-phosphorylatable S800A, or a phosphomimetic
S800E mutant, under the control of tetracycline-regulatable
promoter were produced. For cells expressing wild type Kv2.1,
we were able to record a typical voltage gated outward K cur-
rent upon tetracycline induction (Fig. 4A) that could be stimu-
lated by oxidant (DTDP) treatment. Currents were augmented
3.5–4 fold by DTDP treatment over the voltage range 10 mV
to 60 mV.
As expected, the S800A mutant showed an attenuated cur-
rent density thatwas non-responsive to oxidant treatment, (Fig.
4B), as this mutant lacks the key phosphorylation residue for
FIGURE 4. Kv2.1 ion channel activity is regulated by serine 800 phosphor-
ylation. Whole-cell patch clamp recordings of Kv2.1 K currents. HEK293 cell
lines expressing wild type Kv2.1 (A), S800A (non-phosphorylatable mutant: B)
or S800E (phosphomimetic mutant: C) were subjected to whole cell patch
clamp in the presence (E) or absence (●) of the oxidant DTDP (n  3). Insets
show representative traces of K currents in patch-clamp recordings
obtained by step depolarizations applied from a holding potential of 70 mV
to between 100 mV and 60 mV, in 10-mV increments. Top; trace without
DTDP stimulation, below: with DTDP stimulation (D) HEK293 Kv2.1 cells were
incubated with tetracycline to induce Kv2.1 expression, and/or DTDP to
induce oxidative stress. Proteins expressed on the plasma membrane of
HEK293 Kv2.1 cells were biotin-labeled and harvested samples were probed
by Western blot with anti-Kv2.1 antibody (top panel). Whole cell lysates were
also probed with the total Kv2.1 (middle). Comparable amount of Kv2.1 pro-
teins were expressed following addition of tetracycline. GAPDH detection
was performed as a control (bottom).
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trafficking andmembrane insertion following stress activation.
By contrast the S800E mutant exhibited constitutive activity,
giving rise to large outward K currents regardless of DTDP
stimulation (Fig. 4C). These data confirm that S800 phosphor-
ylation of Kv2.1 is a key event in the control of channel activity
in the inducible cell lines employed in this study. These data
correlated with the cell surface expression of Kv2.1 as detected
by biotinylation of cell surface proteins followed by streptavi-
din-agarose precipitation and Western blotting for Kv2.1 (Fig.
4D, top panel). However, it is noteworthy that, byWestern blot-
tingwith an antibody specific for the S800 phosphorylated form
of Kv2.1, we did not observe a concomitant increase in S800
FIGURE 5. NS5A suppresses Kv2. 1 channel activity. HEK293 cells express-
ing Kv2.1 were transfected with bicistronic vectors encoding NS5A and GFP,
or GFP alone (shown in Fig. 1B). At 24 h after transfection, Kv2.1 expression
was induced by tetracycline treatment for 12 h, prior to electrophysiological
analysis either without (A), or following (B) of DTDP stimulation (n  6). Insets
show representative traces of outward K currents in patch-clamp record-
ings. Top; control trace in GFP-expressing cells, below: trace from cells
expressing NS5A and GFP. C, comparison of current density measurements
from A and B at 40 mV. *, p 	 0.002, **, p 	 0.02, unpaired t test.
FIGURE 6. Endogenous MLK3 contributes to phosphorylation activation
of Kv2. 1 HEK293 cells expressing Kv2.1 were infected with lentiviral
vectors expressing shRNA targeting either MLK3 or GFP. After 6 days, cells
were analyzed by quantitative-RT-PCR (A) or Western blotting (B). A, absolute
quantitation of both MLK3 and GAPDH mRNA was performed and shown as a
ratio. B, Western blotting with indicated antibodies. Cells were infected as
follows: lanes 1: control (empty) lentiviral vector infection, lanes 2: lentiviral
vector expressing shGFP, lanes 3: lentiviral vector expressing shMLK3. GAPDH
was detected as a control. Western blots were quantitated by densitometry to
show a reduction in Kv2.1 S800 phosphorylation following MLK3 knock-
down. C, electrophysiological measurements of Kv2.1-mediated outward K
currents from shRNA-expressing cells. D, comparison of current density mea-
surements at 40 mV from shRNA-expressing cells. *, p 	 0.001, unpaired t
test.
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phosphorylation following DTDP treatment. Clearly there is a
high level of basal S800 phosphorylation in HEK293 cells and
other events such as Kv2.1 Y124 phosphorylation might be
playing a role in cell surface expression of activeKv2.1.Our data
are consistent with a key role for S800 in the oxidant-induced
cell surface expression and activity of Kv2.1, because both the
S800A and S800Emutants are non-responsive to DTDP (Fig. 4,
B and C).
We previously demonstrated that HCV genotype 1b NS5A
fused to GFP was able to inhibit basal Kv2.1 activity in Huh7
cells (14). To confirm that this phenotypewas also a property of
the JFH-1NS5A,andto test the requirement forS800phosphor-
ylation, we transfected the tetracycline inducible HEK293
Kv2.1 cell lines with a bicistronic vector encoding NS5A and
GFP, (Fig. 1B). Following the addition of tetracycline, whole cell
recordings were performed from GFP-positive cells. JFH-1
NS5A also effectively suppressed channel activity by up to 50%
either without or with oxidative stimuli (Fig. 5,A and B, respec-
tively). As shown in Fig. 5C, the current densities measured at
40 mV were reduced by 50% in NS5A-expressing cells in
both cases.
Endogenous MLK3 Is Required for S800 Phosphorylation
Activation of Kv2.1—To investigate if MLK3 was involved in
regulating Kv2.1 channel activity, we performed shRNA-medi-
ated knock down of MLK3. Tetracycline-inducible HEK293
Kv2.1 cells were infected with lentiviral vectors to deliver
shRNA targetingMLK3 (shMLK3) or targetingGFP (shGFP) as
a control. RNA interference achieved75% reduction ofMLK3
in transcriptional level (Fig. 6A), leading to a significant reduc-
tion of MLK3 protein expression (Fig. 6B, lane 3, top panel).
Interestingly, impaired MLK3 expression caused an attenua-
tion of Kv2.1 S800 phosphorylation (Fig. 6B, lane 3, 2nd panel).
In accordance with this observation, K outward currents car-
ried by Kv2.1 were measured by whole cell patch clamp from
MLK3 knock down cells, and were found to be reduced by 80%,
compared with control (Fig. 6, C and D). Altogether, these
results imply that MLK3 can regulate the function of the Kv2.1
channel. Therefore, NS5A binding to, and inhibition of, MLK3
could also affect Kv2.1 channel activity.
MLK3 Activation of Kv2.1 Is Inhibited by NS5A—To investi-
gate whetherMLK3 is directly involved in p38MAPKmediated
Kv2.1 activation, we transfected tetracycline inducible HEK293
Kv2.1 cells with a bicistronic vectors expressing either wild type
or the K144E kinase-inactive mutant of MLK3, together with
GFP, and performed whole-cell patch clamp recordings from
GFP-positive cells. Exogenous expression of wild type MLK3
significantly enhanced Kv2.1 channel activity (Fig. 7, A–C),
while the K144E kinase-inactive mutant showed a dominant
negative effect in terms of phosphorylation activation of Kv2.1.
To further demonstrate the activation of Kv2.1 in response to
MLK3 overexpression, we investigated both p38MAPK activa-
tion and Kv2.1 phosphorylation in cells expressing wild type
FIGURE 7. MLK3 acts as an upstream regulator of Kv2. 1 channel via
Ser800 phosphorylation. A, HEK293 cells expressing Kv2.1 were transfected
with bicistronic vectors expressing MLK3 (wild type or K144E) together with
GFP or NS5A-GFP as shown in Fig. 1B. 16 h post-transfection, Kv2.1 expression
was induced by tetracycline treatment, and 8 h later GFP-positive cells were
identified by fluorescent microscopy and subjected to electrophysiological
recordings. Overexpression of MLK3 wild type augments Kv2.1 channel activ-
ity (f), whereas, the K144E kinase-inactive mutant suppressed channel activ-
ity (Œ). Co-expression of NS5A-GFP abrogated the MLK3 mediated enhance-
ment of Kv2.1 activity (). B, comparison of current density measurements at
40 mV. *, p 	 0.02, **, p 	 0.001, and ***, p 	 0.005, unpaired t test. C,
representative traces of outward K currents in patch-clamp recordings. D,
lysates from HEK293 cells expressing Kv2.1 wild type were analyzed by West-
ern blotting with the indicated antibodies. Cells were transfected as follows:
lane 1: empty vector, lane 2: NS5A-IRES-GFP, lane 3: MLK3 wild type-IRES-GFP,
and lane 4: MLK3 K144E-IRES-GFP.
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andK144EMLK3.Western blotting analysis demonstrated that
MLK3 overexpression led to the activation of both p38MAPK
and subsequent Kv2.1 S800 phosphorylation (Fig. 7D, lane 3),
which was not observed following transfection of K144EMLK3
(Fig. 7D, lane 4). As NS5A interacts with MLK3 (as shown in
Fig. 1), we hypothesized that the inhibition of Kv2.1 activity by
NS5A may be mediated through MLK3 inhibition. Accord-
ingly, when cells were transfected with a bicistronic vector
expressing wild type MLK3 and an NS5A-GFP fusion protein,
the levels of Kv2.1 activity were significantly reduced, suggest-
ing that NS5A inhibits the stimulatory effects of MLK3 on
Kv2.1 activity (Fig. 7, A and B).
DISCUSSION
In this study we set out to investigate the molecular mecha-
nism by which the HCV NS5A protein inhibits the activity of
the Kv2.1 potassium channel. This investigation led us to the
observation that NS5A interacts with, and inhibits, theMAP3K
MLK3. This has a number of potential functional conse-
quences, two of which we have investigated further. A sche-
matic model of the effects of NS5A on MLK3 and the down-
stream consequences is presented in Fig. 8. First, inhibition of
MLK3 abrogates the well-characterized pro-apoptotic role of
this kinase. MLK3 was first shown to be pro-apoptotic nearly a
decade ago (17), and more recently has been shown to be
involved in apoptosis in both pancreatic -cells (29) and hepa-
tocytes (18) where it was shown to contribute to acetamino-
phen-induced oxidative stress and hepatotoxicity. Intriguingly,
MLK3 was recently shown to be activated by the hepatitis B
virusXprotein (HBx) leading to increased apoptosis in cultured
HepG2 cells (30). In relation to HCV infection, inhibition of
MLK3 is therefore potentially important to allow the survival of
infected cells and the establishment of a persistent infection. In
this regard it is noteworthy that HCV causes elevated intracel-
lular ROS production mediated by iron overload (31), deregu-
lation of ERCa2 storage (ER stress) (32), and directmitochon-
drial ROS production (33). Elevated ROS production can in
turn suppress HCV replication (34) and cause a range of path-
ological features including apoptosis, steatosis, DNA damage,
and tumorigenesis (35).
It is important to note that as well as inhibition of MLK3,
NS5A targets other cellular pathways to that would potentially
block apoptosis and contribute to tumorigenesis. In this regard
both we (36, 37), and others (38, 39), have demonstrated that
NS5A activates the proto-oncogene -catenin, leading to its
stabilization and stimulating -catenin-dependent tran-
scription. Intriguingly, MLK3 has been shown to inhibit
-catenin-dependent transcription while paradoxically sta-
bilizing -catenin (40). It is therefore likely that NS5A could
utilize multiple mechanisms to stimulate -catenin, both by
directly binding to it and indirectly by inhibiting MLK3.
Clearly, HCV must benefit from the stimulation of -catenin
activity as it has evolved multiple mechanisms to ensure that
this occurs during infection.
The second consequence ofMLK3 inhibition is that there is a
concomitant inhibition of p38MAPK-mediated phosphoryla-
tion of the K channel; Kv2.1. Kv2.1 channel activity has been
associated with the induction of apoptosis in neurons (10, 13,
41), and indeed recent observations suggest thatNS5A is able to
block Kv2.1-mediated apoptosis in cultured rat neurons (42).
However, in the present study, we were not able to observe
elevated levels of apoptosis in either HEK293 or Huh7 cells
following overexpression of Kv2.1 (data not shown). We con-
FIGURE 8. A model of NS5A interference with MLK3/p38/Kv2.1 signaling. HCV infection and RNA replication triggers the elevated production of reactive
oxygen species (ROS), which activates MLK3, leading to activation of p38MAPK. In turn p38MAPK phosphorylates serine 800 of Kv2.1, which is a key phospho-
rylation event involved in the insertion of Kv2.1 into the plasma membrane. The upsurge in the efflux of K lowers the intracellular concentration of K, causing
an alteration of ionic homeostasis. At the same time MLK3 stimulates the induction of apoptosis. In this study, we show that NS5A inhibits MLK3 activation,
thereby blocking both the phosphorylation and activation of Kv2.1, and MLK3-mediated apoptosis.
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clude therefore, that the induction of apoptosis we observed
previously inHuh7 cells treatedwithDTDP (14)was coincident
with stimulation of Kv2.1 activity, and not dependent upon the
latter. Both the induction of apoptosis and the stimulation of
Kv2.1 activity could be inhibited by NS5A in a P2motif-depen-
dent manner. In the present study we show that both of these
effects can be explained by interactions between NS5A and
MLK3. Although alanine substitution of the conserved prolines
in the P2 motif does not affect viral fitness or replication (23),
the same mutation caused a greater sensitivity to oxidative
stress-induced apoptosis (14). Additionally, the P2 motif was
shown to be important for the establishment of infection in the
chimpanzee model (43). Coupled with our previous observa-
tion that primary hepatocytes weremuchmore sensitive to oxi-
dative stress than Huh7 (14), we propose that the P2 motif may
play a role in virus persistence by blocking the induction of
apoptosis in infected hepatocytes. This could explain the abso-
lute conservation of this motif in all HCV isolates.
As mentioned above, a recent study revealed that NS5A of a
different genotype (1b) effectively blocked Kv2.1mediated cur-
rents without interfering with S800 phosphorylation but by
suppressing Y124 phosphorylation, which is mediated by c-Src
kinase (42). The data discrepancy may be due to different
experimental conditions (e.g. cell type), although it is still note-
worthy to mention that NS5A targets c-Src kinase (44). A
recent report (45) demonstrated that S440 and S537 of Kv2.1
are substrates of AMP-activated protein kinase (AMPK). Since
we have shown that AMPK activation was significantly
impaired byHCV infection (46), it will be of great interest to see
how Kv2.1 phosphorylation by AMPK is affected during either
HCV infection or NS5A expression. Furthermore, a body of
etiological evidence shows thatHCV infection causes a range of
metabolic disorders in patients, for instance fatty liver and insu-
lin resistance. Future studies will hopefully establish how viral
suppression or deregulation of Kv2.1 could contribute to such
metabolic alterations caused by HCV.
Overall this study demonstrates that the SH3-binding P2
motif of NS5A can bindMLK3 to both suppress oxidative stress
induced outward K currents, and inhibit host cell apoptosis.
This may facilitate themaintenance of long term viral infection
and in turn may enable HCV to establish a persistent infection.
Understanding the mechanisms of NS5Amodulation of MLK3
and Kv2.1 provides a target for the development of novel anti-
virals that may trigger apoptosis in HCV infected hepatocytes.
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